Vemlidy 25 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F66K0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,132
Award facts
- Contract value 100% obligated
- $14,132.04 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded on January 22, 2026, provides Vemlidy 25 mg tablets in quantities of 30 units to the Defense Logistics Agency through its prime pharmaceutical supply vehicle. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., received this competitively awarded, non-set-aside order with a ceiling value of $14,132.04 under firm fixed-price terms. The order is scheduled for completion by January 23, 2026, and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. Vemlidy is an antiviral medication used in the treatment of chronic hepatitis B, representing part of the broader pharmaceutical supply requirements for military and federal healthcare systems.
This delivery order is issued under Cencora, Inc.'s comprehensive Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical, valued at up to $999,999,999 and extending through December 2031. The parent IDC serves as a global pharmaceutical support vehicle enabling supply of a diverse range of medications, medical devices, vaccines, and related healthcare commodities to military treatment facilities, the Defense Health Agency, U.S. Coast Guard, and other federal medical institutions. The award reflects AmerisourceBergen's continued role as a critical pharmaceutical distributor within the federal supply chain, maintaining capability to deliver specialized medications across multiple therapeutic domains on a competitive basis.
Quick answers
Who was awarded contract SPE2DR26F66K0?
SPE2DR26F66K0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26F66K0 worth?
The government has obligated $14,132 on SPE2DR26F66K0.
Is contract SPE2DR26F66K0 an order under another contract?
Yes. SPE2DR26F66K0 is a delivery order under SPE2DR25D3303, an indefinite delivery contract.
Was contract SPE2DR26F66K0 competed?
The extent of competition for SPE2DR26F66K0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award